Basics Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. IPO Date: November 10, 2014 Sector: Healthcare Industry: Biotech Market Cap: $4.41B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.67% Avg Daily Range (30 D): $1.38 | 1.64% Avg Daily Range (90 D): $1.49 | 2.07% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): 1.12M Avg Daily Volume (90 D): 1.19M Trade Size Avg Trade Size (Sh.): 161 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 1,481 Avg Inst. Trade: $2.64M Avg Inst. Trade (30 D): $6.07M Avg Inst. Trade (90 D): $3.48M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.54M Avg Closing Trade (30 D): $15.1M Avg Closing Trade (90 D): $9.54M Avg Closing Volume: 82.03K     News Jul 10, 2025 @ 10:00 AM Soleno Therapeutics Announces Preliminary Financia... Source: Brian Ritchie, Lifesci Advisors, Llc May 22, 2025 @ 9:32 PM Soleno Therapeutics Announces Submission and EMA V... Source: N/A Feb 21, 2025 @ 6:00 PM Evolving Landscape of Obesity: Key Market Insights... Source: Delveinsight Nov 27, 2024 @ 1:00 PM Soleno Therapeutics to Participate in Piper Sandle... Source: Na Jul 20, 2024 @ 2:42 AM Soleno Therapeutics enters agreement to sell $150 ... Source: Investing.Com Financials   TTM Q4 2024 FY 2024 Basic EPS $-.95 $-1.3 $-4.38 Diluted EPS $-.95 $-1.3 $-4.38 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -43.77M $ -55.98M $ -175.85M Operating Income / Loss $ -45.74M $ -59.12M $ -187.67M Cost of Revenue $ $ $ Net Cash Flow $ -6.6M $ 39.52M $ -81.75M PE Ratio     Splits Aug 26, 2022:   1:15 Oct 06, 2017:   1:5